TWO · 4735.TWO
AViTA Corporation
NT$35.95-NT$0.35 (-0.96%)
AViTA Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.89% below the high.
Loading market information…
TWO · 6767.TWO · TWD
Stock price, earnings
Quote as of Oct 30, 2026, 05:12 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Wiltrom Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Wiltrom Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Wiltrom Co., Ltd., an enterprise headquartered in Zhubei, Taiwan, specializes in the research, development, manufacturing, and global distribution of advanced implantable medical devices. Established in 2009, the company provides a diverse portfolio of surgical solutions to both domestic and international markets. Its comprehensive offerings include systems for spinal fixation, interbody fusion devices, synthetic bone graft substitutes, vertebral body augmentation systems, and specialized bone cement for vertebroplasty procedures.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:49 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$35.95-NT$0.35 (-0.96%)
AViTA Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.89% below the high.
NT$22.55-NT$0.35 (-1.53%)
Bio Preventive Medicine Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.98% below the high.
NT$46.00NT$0.00 (0.0%)
S&S Healthcare Holding Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.38% below the high.
NT$30.60-NT$0.05 (-0.16%)
Level Biotechnology Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.82% below the high.
NT$15.40-NT$0.65 (-4.05%)
AmCad BioMed Corporation’s quoted price sits in the upper half of its reported 52-week range, 18.3% below the high.
NT$13.95-NT$0.05 (-0.36%)
LAUNXP Biomedical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 45.19% below the high.
NT$18.70+NT$0.20 (+1.08%)
Lukas Biomedical Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.46% below the high.
NT$11.80-NT$0.15 (-1.26%)
Cowealth Medical Holding Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.93% below the high.
